The global legionella testing market is expected to grow at a
considerable rate over the forecast period owing to the advancements and
automation in the immunodiagnostic market such as the introduction of
advanced ELISA antibodies for the prevention of legionnaires diseases in
the market. The rapidly rising awareness about legionella based
diseases and the increase in demand for advanced immunodiagnostic
techniques is a direct consequence of rapidly increasing incidences of
mild flu and pneumonia like diseases through legionella bacteria.
Browse Detail Report With TOC @ http://www.hexaresearch.com/research-report/legionella-testing-industry/
Since legionella bacteria requires the presence of iron and cysteine
to grow, it is traditionally detected by culture on buffered charcoal
yeast extract. This process takes 4 to 5 days for detectingthe
legionella bacteria. The advanced immunological techniques such as
polymerase chain reaction and rapid immunological assays are efficient
to detect the legionella bacteria in few minutes. These techniques are
commonly used to establish the presence of species of Legionella
bacteria in the sample.
Some of the other drivers for the growth of the global legionella
testing market include the entry of new players, new emerging economies
such as China and India and increase in the funding for healthcare
facilities by the government in many regions. There are about 40
different species of legionella bacteria out of which 18 species are
infectious. Among all these species, the legionella pneumophilla
bacterium can cause most of the diseases. Many hospitals have started
various tests such as legionella urinary antigen test for the initial
detection of legionella based diseases. This is the factor expected to
further fuel the legionella testing market over the forecast period.
Request A Sample copy of This Report @ http://www.hexaresearch.com/sample/132
The legionella testing market has been divided on the basis of
antibiotics used for the treatment of legionella infections into
rifampin, azithromycin, ketolides, quinolones and macrolides. It is
expected that Azithromycin drug will grow at the fastest rate throughout
the forecast period owing to its efficiency to treat legionella based
diseases. Azithromycin drug is mainly used for treating this infection
in children and adults. The increasing incidences of legionella based
diseases in children and adults is also a factor driving the
Azithromycin drug segment in the market.
Apart, certain flouroquinolones such as moxifloxacin and levofloxacin
are also considered as the most efficient drugs for legionella based
diseases. There are several diagnostic tests which are available
commercially in the market for initial detection of Legionella bacteria
in the body such as sputum or lung tissue test, urine antigen test,
chest X-ray and blood test. There are various end users of legionella
testing drugs which include hospitals, commercial or private labs,
physician offices and public health labs.
Major regions estimated for the legionella testing market are North
America, Europe, Asia Pacific and RoW. As of 2013, North America
dominated the market attributing the largest share in terms of revenue.
This large share can be accounted for by the increasing number of
patients suffering from legionella based diseases, the presence of large
number of market players and government initiatives such as various
public health labs across the region. Owing to the new emerging
economies such as Germany and U.K. and rising awareness about legionella
based diseases in the Europe region, it is expected that this region
will show lucrative growth in the global legionella testing market over
the forecast period.
The key participants in the legionella testing market include Roche
Diagnostics, Beckman Coulter, Bio Rad, Novartis Diagnostics, Life
Technology, Becton Dickinson, Abott laboratories, Eiken Chemical, ID
Biomedical, Thermo Fischer, Takara Bio, Kreatech, Gen Probe, Enzo
Biochem and SeraCare. The market leaders in the global legionella
testing market are involved in continuous efforts for the development of
innovative methodologies of testing which would increase the efficiency
and accuracy of test results while providing the smooth processing of
larger samples simultaneously. This companies are also entering into
strategic collaborations and expansions to extend their global patient
base.
Browse Full Report @ http://www.hexaresearch.com/research-report/legionella-testing-industry/
About Us:
Hexa Research is a market research and consulting organization,
offering industry reports, custom research and consulting services to a
host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients
obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Website - http://www.hexaresearch.com/
Visit our Blog: http://hexaresearchinc.blogspot.com/
No comments:
Post a Comment